
Innovacell
Operator of a biotechnology company intended to develop, produce, and market cell therapies for treating fecal and urinary incontinence. The company offers a minimally invasive administration of cell ...
Valuation
$216.7M
Latest known
Share Price
N/A
Total Raised
$120.2M
Last Round
N/A